Miyoko Christina Yi - Dec 16, 2021 Form 4 Insider Report for Provention Bio, Inc. (PRVB)

Role: Chief Operations Officer
Signature: /s/ Thierry Chauche
Stock symbol: PRVB
Transactions as of: Dec 16, 2021
Transactions value $: $0
Form type: 4
Date filed: 12/20/2021, 04:02 PM
Next filing: Jan 20, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PRVB	Stock Option (right to buy)	Award	$0	+150K		$0.00	150K	Dec 16, 2021	Common Stock, par value $0.0001	150K	$5.88	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On December 16, 2021 the Reporting Person was granted a stock option for 150,000 shares of Common Stock which vests in four equal annual installments commencing on December 16, 2021. Reporting Person was also granted 150,000 stock options under the Issuer's 2020 Inducement Plan with performance-based vesting triggers that will be reported, if and when vested, consistent with the applicable reporting requirements.
F2	The stock options were granted pursuant to the Issuer's 2020 Inducement Plan.

Content

On December 16, 2021 the Reporting Person was granted a stock option for 150,000 shares of Common Stock which vests in four equal annual installments commencing on December 16, 2021. Reporting Person was also granted 150,000 stock options under the Issuer's 2020 Inducement Plan with performance-based vesting triggers that will be reported, if and when vested, consistent with the applicable reporting requirements.

The stock options were granted pursuant to the Issuer's 2020 Inducement Plan.